Literature DB >> 123972

Cardiomegaly in chronic anemia in ratsman experimental study including ultrastructural, histometric, and stereologic observations.

B N Datta, M D Silver.   

Abstract

Postweanling rats maintained on a milk-sugar diet develop a sideropenic anemia, the hemoglobin values falling to less than 30 per cent within 8 to 10 weeks. In that period the heart weight increases by more than 3 times, both ventricles enlarging proportionately. As in other forms of cardiac hypertrophy, a progressive increase in the numbers of connective tissue cells occurs. Ultrastructural and stereologic studies show an appreciable proliferation of the mitochondrial mass in myocardial cells, the mitochondrial fractional volume increasing from a normal of 0.38 to 0.48 per unit cell volume. This quantitative increase is accompanied by a progressive deterioration of the internal cristal structure and the appearance of abnormal, degenerating, and necrotic forms of mitochondria as congestive cardiac failure develops. Myofibrils remain normal. The heart of an anemic rat subjected to an additional workload produced by subdiaphragmatic aortic constriction shows an earlier deterioration of the mitochondrial ultrastructure and stereologic profiles. However, it does not become as large as the heart of the purely anemic animal. In anemic animals with an increased workload, the myofibrillar fractional volume increases from a normal of 0.52 to 0.57 per unit cell volume initially. The active sarcomerogenesis is achieved by Z-band proliferation, which was not observed in the heart of the purely anemic animal. These findings provide a structural basis for the functional and biochemical cardiac deterioration observed in the cardiomegaly induced by chronic anemia.

Entities:  

Mesh:

Year:  1975        PMID: 123972

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats.

Authors:  G Olivetti; F Quaini; C Lagrasta; R Ricci; G Tiberti; J M Capasso; P Anversa
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  An effective morphometric method for electron microscopic studies on papillary muscles.

Authors:  G Mall; H Reinhard; K Kayser; J A Rossner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-09-07

3.  Ultrastructure of failing myocardium due to induced chronic mitral insufficiency in dogs.

Authors:  K Prasad; P K Singal
Journal:  Br J Exp Pathol       Date:  1977-06

4.  Synergistic effects of diabetes mellitus and renovascular hypertension on the rat heart--stereological investigations on papillary muscles.

Authors:  G Mall; K Klingel; H Baust; C Hasslacher; J Mann; T Mattfeldt; R Waldherr
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Morphometric analysis of the isolated calcium-tolerant cardiac myocyte. Organelle volumes, sarcomere length, plasma membrane surface folds, and intramembrane particle density and distribution.

Authors:  N J Severs; A M Slade; T Powell; V W Twist; G E Jones
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

Review 6.  [Angina pectoris in extracoronary diseases].

Authors:  A Wilke; B Noll; B Maisch
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 7.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

Review 8.  Heart failure and anemia: mechanisms and pathophysiology.

Authors:  Inder S Anand
Journal:  Heart Fail Rev       Date:  2008-01-31       Impact factor: 4.214

9.  The Role of Treatment for Anemia as a Therapeutic Target in the Management of Chronic Heart Failure: Insights After RED-HF.

Authors:  Hanna K Gaggin; G William Dec
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

10.  [Angina pectoris in leiomyoma].

Authors:  A Wilke; T Kruse; B Maisch
Journal:  Herz       Date:  1998-08       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.